AtaiBeckley (ATAI) Revenue (2021 - 2026)

AtaiBeckley's (ATAI) quarterly Revenue came in at $749000.0 in Q3 2025, up 1772.5% year-on-year from $40000.0 in Q3 2024, and up 4.17% quarter-over-quarter from $719000.0 in Q2 2025.

AtaiBeckley (ATAI) Revenue (2021 - 2026) Analysis & Trends

AtaiBeckley has disclosed Revenue across 5 years of filings, most recently posting $749000.0 for Q3 2025.

  • Revenue for Q3 2025 came in at $749000.0, up 1772.5% year-over-year; the trailing twelve-month figure through Sep 2025 was $3.0 million (up 816.92% YoY), and the FY2024 annual result was $308000.0, down 1.91% from the prior year.
  • Revenue was $954000.0 for Q1 2026 at AtaiBeckley, down from $1.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.6 million in Q1 2025 to a low of $12000.0 in Q4 2024.
  • Historically, Revenue has averaged $840333.3 across 3 years, with a median of $954000.0 in 2026.
  • Across the five-year window, Revenue slumped 90.98% in 2022 and surged 1772.5% in 2025, its largest moves.
  • A 3-year view of Revenue shows it stood at $12000.0 in 2024, then jumped by 12858.33% to $1.6 million in 2025, then tumbled by 38.65% to $954000.0 in 2026.
  • The last three Revenue figures came in at $954000.0 (Q1 2026), $1.6 million (Q1 2025), and $12000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 AtaiBeckley 1.45 Bn 1.45 Bn - 954,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 954,000.00
Sep 30, 2025 749,000.00
Jun 30, 2025 719,000.00
Mar 31, 2025 1.56 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 12,000.00
Dec 31, 2024 12,000.00
Sep 30, 2024 40,000.00
Jun 30, 2024 273,000.00
Dec 31, 2023 18,000.00
Sep 30, 2023 87,000.00
Jun 30, 2023 172,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 24,000.00
Jun 30, 2022 170,000.00
Dec 31, 2021 230,000.00
Sep 30, 2021 266,000.00
Mar 31, 2021 19.88 Mn